Marinomed

Marinomed Biotech AG is a biopharmaceutical company. It focuses on developing innovative products based on patented technology platforms in the fields of respiratory and ophthalmic diseases. Marinomed's efforts have been recognized with multiple prestigious research awards. To date, Marinomed has developed two platforms: the Marinosolv® technology platform and the Carragelose® platform.The Marinosolv® technology platform enhances the efficacy of poorly soluble compounds. This innovative technology has the potential to sustainably transform therapies for various allergic and autoimmune diseases. The Carragelose® platform has been utilized in six different products for the treatment of respiratory viral infections, which have been globally marketed through the company’s partners.